EUCTR2011-003509-65-IT进行中（未招募）不适用
Weekly therapy with Carboplatin and Docetaxel in patients with head-neck cancer with important comorbidity - HK2010
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Head and Neck Squamous Cell Carcinoma, High Comorbidity, Adequate bone marrow, hepatic and renal function, Age>18, signed Informed Consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 11
排除标准
- •Psychosis, alcoholism,other cancers,renal or hepatic impairment, inadequate bone marrow function, uncontrolled diabetes mellitus, inadequate left ventricular function.
研究者
相似试验
已完成
1 期
Phase I/II study of biweekly docetaxel, cisplatin, and S-1 combination neoadjuvant chemotherapy in patients with stage III gastric cancergastric cancerJPRN-UMIN000011625Yokohama City University Medical Center51
已完成
不适用
Docetaxel and Carboplatin once every 3 weeks versus weekly Docetaxel in advanced non-small cell lung cancer: a Multicenter phase III study from the Dutch Chest Physician Association.on small cell lung cancer (NSCLC)NL-OMON28184MCGDepartment Pulmonary Diseases440
已完成
2 期
Phase II Study of Carboplatin +Docetaxel +Bevacizumab in Chemo-Naive Patients with stage IIIB and IV Non-Squamous Non-Small-Cell Lung CancerChemo-Naive Patients with stage IIIB and IV Non-Squamous Non-Small-Cell Lung CancerJPRN-UMIN000004524The Tokyo cooperative oncology group40
已完成
2 期
Phase II study of Carboplatin, weekly Paclitaxel and Bevacizumab in elderly patients with advanced non-squamous non-small-cell lung cancer (NEJ 016)non-small cell lung cancerJPRN-UMIN000006622orth East Japan Study Group36
已完成
2 期
Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Groupon-small cell lung cancerJPRN-UMIN000001132iigata Lung Cancer Treatment Group80